Voyager Therapeutics Inc (NASDAQ: VYGR) stock closed at $7.04 on 8/7/24 after a major decline of -14.0%. Moreover, this decline was accompanied by above average trading volume at 138% of normal. The stock has declined -24.0% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
VYGR’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to be a modest Value Eraser.
Voyager Therapeutics has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Voyager Therapeutics has a poor Appreciation Score of 26 but a slightly positive Power Rating of 68, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment